|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 14, 2019 ) China Conjugate Vaccine Market:Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. China is one of the prominent markets with a significant growth rate for conjugate vaccines.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/china-conjugate-vaccine-market/11299/#requestforsample
All Expanded Program on Immunization (EPI) vaccines (including tuberculosis, polio, measles, and diphtheria-tetanus-pertussis (DTP), hepatitis A and B, meningococcal, Japanese encephalitis, rubella and mumps) in China are free and mandatory for school admissions. Immunization clinics in China also offer non-EPI vaccines to children but for a fee (and are not covered by insurance programs), including influenza, varicella, Haemophilus influenza type B (Hib), rotavirus, and pneumococcal vaccines, among others.
Market Segmentation:
By disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type B
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others
By end user, the market is segmented into:
o Paediatric
o Adult
Key growth factors:
China is projected to be a significant market for conjugate vaccines during the forecast period. Rapidly increasing geriatric population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the conjugated vaccines market in China. According to the United Nations, China is ageing more rapidly than almost any country in recent history. This acts as a key driver for adult vaccines, owing to more demand by the geriatric population. Since the toll of pneumococcal disease in China is enormous, pneumococcal vaccination could improve children’s health and save lives and is therefore a prime selection for inclusion in the EPI schedule.
Threats and key players:
o The China Conjugate Vaccine Market is expected to have significantly high growth. China has spent tremendous resources on the elimination of measles, but such elimination efforts should be combined with other immunization initiatives, such as educating caregivers about the benefits of other vaccines. The Chinese public is receiving more information about measles than about pneumonia or meningitis. Measles vaccine is free in Shanghai, but pneumococcal vaccine requires payment, which impacts the decision of the public significantly as they are reluctant to pay and get vaccinated.
.......
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/china-conjugate-vaccine-market/11299/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. China market overview – by revenue
- China historical (2015-2017) market revenue (USD Bn)
- China forecasted (2018-2023) market revenue (USD Bn)
2.3. China market overview – by volume
- China historical (2015-2017) market volume (Million units)
- China forecasted (2018-2023) market volume (Million units)
2.4. China market drivers and challenges
2.4.1. China market drivers
2.4.2. China market challenges
2.5. China market trends
2.6. Value chain
Chapter 3: China major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – China (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib – China (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – China (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal – China (USD Bn, Million units)
Chapter 4: China major segment overview - by end user
4.1. End-user: Pediatric, Adult - by revenue, by volume, by CAGR
- Overview - by end-user
- Market share (2015, 2018 & 2023): Paediatric – China (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult – China (USD Bn, Million units)
Chapter 5: Competitive landscape
5.1. Company market share
- Top 5 companies
5.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.2(A) Executive profile – GlaxoSmithKline
5.3. Company overview – Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.3(A) Executive profile - Pfizer Inc.
5.4. Company overview – Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.4(A) Executive profile - Merck & Co.
5.5. Company overview – Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
......
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/china-conjugate-vaccine-market/11299/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on: <||>rnhttps://www.facebook.com/reasearchreporthub/ <||>rnhttps://twitter.com/hub_report <||>rnhttps://www.linkedin.com/company/research-report-hub/
Research Report Hub
Prakriti Mathur
+918448444687
sales@researchreporthub.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
